We thank the reviewer for identifying this mistake, and have corrected this, changing the label of the LC3 data to e.
Beclin-1 levels were increased more than 4-fold relative to control in all treatment groups, while intensity of LC3 staining was increased about 3-fold relative to control in the individual TTFields and sorafenib groups, but only 2-fold in the combination group (Figure 4e).